Clinical Trial Update: Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating dual-target GPC3/B7-H3 CAR-NK cells for advanced hepatocellular carcinoma and metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastasis

Drugs mentioned

• GPC3/B7-H3 CAR-NK cells (CAR-NK cells targeting GPC3 and B7-H3)

Snippet

Sponsor: Beijing Biotech | Conditions: Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer | Phase 1, Phase 2 | Status: RECRUITING